Breast Cancer - HER2 Test Approved | ThirdAge
Links shared publicly online about this topic.
- 217total visits
Breast Cancer - HER2 Test Approved | ThirdAge
View full resource at thirdage.com
Tags: Genetic, Cancer, Breast Cancer, Drug, Lab Test, Women's Health, Herceptin
Most Recently Shared on June 15, 2011 at 4:22 pm By:
Breast Cancer - HER2 Test Approved http://bit.ly/lgX2L0
Hologic receives FDA approval for Cervista HTA system to detect cervical cancer
news-medical.net — “Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration (FDA) has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus (HPV) HR test.” View full resource at news-medical.net
Most Recently Shared on December 16, 2011 at 5:30 am By:
Hologic receives FDA approval for Cervista HTA system to detect cervical cancer: Hologic, Inc., a leading develo... http://t.co/M2lDRljr
Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center
news-medical.net — “Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.” View full resource at news-medical.net
Most Recently Shared on December 7, 2011 at 12:59 pm By:
Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center: Aethlon Medical, Inc., the pio... http://t.co/I9Pdn6sn
FDA approves Abbott's Vysis ALK FISH test for NSCLC therapy selection
news-medical.net — “Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.” View full resource at news-medical.net
Most Recently Shared on August 29, 2011 at 6:26 am By:
Breast Cancer News: FDA approves Abbott's Vysis ALK FISH test for NSCLC therapy selection: Abbott today announce... http://t.co/FkNNCBP
Mayo Clinic Cancer Vaccines Approved By FDA | ThirdAge
thirdage.com — “The Mayo Clinic received approval from the Food and Drug Administration for a vaccine to prevent the recurrence of ovarian and breast cancers.” View full resource at thirdage.com
Most Recently Shared on August 18, 2011 at 9:02 pm By:
Mayo Clinic Cancer Vaccines Approved By FDA http://t.co/e1IbZ00
Breast Cancer - Search Is On For The Best Exercise | ThirdAge
thirdage.com — “U.S. researchers are testing exercise's impact on breast cancer survivors at the molecular level.” View full resource at thirdage.com
Most Recently Shared on July 31, 2011 at 8:24 pm By:
Breast Cancer - Search Is On For The Best Exercise http://bit.ly/r98u5R
Breast and ovarian cancer: Myriad Genetics BRCA1 and BRCA2 gene patents get court approval - latimes.com
latimes.com — “A court of appeals has affirmed patents on the BRCA1 and BRCA2 genes held by Myriad Genetics, which sells tests to determine if people carry the gene variants. BRCA1 and BRCA2 increase a woman's likelihood of developing breast or ovarian cancer.” View full resource at latimes.com
Most Recently Shared on July 29, 2011 at 10:44 pm By:
LA Times Health News Health News
Breast cancer: Gene patents get court approval http://lat.ms/qqZoHJ
Ovarian Cancer Genetic Testing Guidelines Ignored | ThirdAge
thirdage.com — “Those who are at average and high risk for ovarian cancer and breast cancer may be missing out on treatments that could reduce their chances of developing the diseases, according to a new study.” View full resource at thirdage.com
Most Recently Shared on July 26, 2011 at 1:52 am By:
Ovarian Cancer Genetic Testing Guidelines Ignored: Those who are at average and high risk for ovarian cancer and... http://bit.ly/pwe2k0
A.M. Vitals: Research Review Links Pfizer’s Chantix to Heart Problems - Health Blog - WSJ
blogs.wsj.com — “Also: HPV testing may be overused; Novartis plans to ask regulators to approve Afinitor for breast cancer; massage and back pain.” View full resource at blogs.wsj.com
Most Recently Shared on July 5, 2011 at 1:02 pm By:
A.M. Vitals: Research Review Links Pfizer’s Chantix to Heart Problems http://on.wsj.com/kDiF1s
FDA approves test that identifies Herceptin candidates - ONA
oncologynurseadvisor.com — “A new genetic test that will help health care providers determine whether women with breast cancer are eligible for treatment with trastuzumab (Herceptin) has been approved by the FDA.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 1, 2011 at 11:32 am By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA approves test that identifies Herceptin candidates http://goo.gl/fb/zQSzW
Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR
npr.org — “In a controversial 2008 decision, the FDA gave fast-track approval for Avastin for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, a panel has recommended that the agency revoke approval, angering patients and the drugmaker.” View full resource at npr.org
Most Recently Shared on June 30, 2011 at 12:37 pm By:
krupali tejura, m.d. Oncologist, Radiation Oncologist, Physician, and Doctor
NPR: Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No-More at http://n.pr/kg0U02
Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR
npr.org — “In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients and the drug's maker.” View full resource at npr.org
Most Recently Shared on June 29, 2011 at 2:31 pm By:
Hisham Rana, MD Doctor and Physician
Commentary: Avastin as breast #cancer treatment tests US #FDA's ability to say no http://n.pr/lLx8Cu - Well said: "Do data matter?" #health
Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR
npr.org — “In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients and the drug's maker.” View full resource at npr.org
Most Recently Shared on June 29, 2011 at 2:03 pm By:
From @dickknox: Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No http://n.pr/koGuyf
Avastin Hearing To Take Place This Week | ThirdAge
thirdage.com — “Avastin, the world’s bestselling cancer drug, will go on trial this week in Roche’s final effort to keep it approved for breast cancer treatment, even though the government believes it to be ill-effective.” View full resource at thirdage.com
Most Recently Shared on June 27, 2011 at 6:51 pm By:
Avastin Hearing To Take Place This Week http://bit.ly/lJkliQ
GA Society of the American College of Surgeons: FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment
gasacs.blogspot.com — “GA Society of the American College of Surgeons: FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment” View full resource at gasacs.blogspot.com
Most Recently Shared on June 20, 2011 at 2:38 am By:
FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For… http://goo.gl/fb/o0AAx
FDA Approves New Test To Help Determine if Breast Cancer Patients... -- SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ --
prnewswire.com — “FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment.” View full resource at prnewswire.com
Most Recently Shared on June 15, 2011 at 6:15 pm By:
Komen Central VA Health Organization
RT @komenscmm: FDA approved a new test to help with breast cancer treatment decisions. Read through this article... http://fb.me/SxyKbDSW
Advertisement
